← Leaderboards
Michael B Zwick
Scripps Research Institute, The
$21,835,418
Attributed
$22,768,468
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,768,468 · 13
By mechanism
R01$18,730,248 · 7
R33$1,670,945 · 1
R21$1,601,566 · 3
R56$765,709 · 2
Top collaborators
- Laurent Karl Verkoczy2 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Jiang Zhu$14,887,050
- Richard Thomas Wyatt$25,384,171
- Andrew Barrett Ward$14,394,344
- Ian A Wilson$64,513,205
- David Nemazee$50,518,228
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyAntigensImmunizationVaccine DesignMembraneResponseAntibodiesDesignEpitopesLeadVaccinesBasePeptidesHiv-1Oryctolagus CuniculusSerumMolecular ConformationVaccine DevelopmentVariantAffinityVirusSpecificityComplexMolecular
Grant awards (39)
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV$912,596
R01 · FY2025 · AI · contact PI
Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV$839,102
R01 · FY2025 · AI · contact PI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV$953,504
R01 · FY2024 · AI · contact PI
Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV$816,634
R01 · FY2024 · AI · contact PI
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines$891,174
R01 · FY2023 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$832,487
R01 · FY2023 · AI · contact PI
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines$1,018,173
R01 · FY2022 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$835,187
R01 · FY2022 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$866,147
R01 · FY2021 · AI · contact PI
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines$822,054
R01 · FY2021 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$866,147
R01 · FY2020 · AI · contact PI
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines$726,229
R01 · FY2020 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$581,917
R01 · FY2019 · AI · contact PI
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes$291,959
R56 · FY2019 · AI · contact PI
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design$574,022
R01 · FY2018 · AI · contact PI
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design$574,022
R01 · FY2017 · AI · contact PI
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design$574,022
R01 · FY2016 · AI · contact PI
Selecting HIV recombination libraries for stable Env trimer immunogens$534,084
R01 · FY2016 · AI · contact PI
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design$565,076
R01 · FY2015 · AI · contact PI
Selecting HIV recombination libraries for stable Env trimer immunogens$525,760
R01 · FY2015 · AI · contact PI
Eliciting antibodies to probe native trimeric gp41 for HIV vaccine design$565,076
R01 · FY2014 · AI · contact PI
Selecting HIV recombination libraries for stable Env trimer immunogens$525,760
R01 · FY2014 · AI · contact PI
Engineering and sorting HIV-1 display Env libraries for vaccine design$534,174
R33 · FY2013 · AI · contact PI
Selecting HIV recombination libraries for stable Env trimer immunogens$494,214
R01 · FY2013 · AI · contact PI
Engineering and sorting HIV-1 display Env libraries for vaccine design$568,271
R33 · FY2012 · AI · contact PI
Selecting HIV recombination libraries for stable Env trimer immunogens$525,760
R01 · FY2012 · AI · contact PI
Investigating an interface between gp120 and gp41 for HIV entry inhibition$189,500
R21 · FY2012 · AI · contact PI
Engineering and sorting HIV-1 display Env libraries for vaccine design$568,500
R33 · FY2011 · AI · contact PI
Covalent trapping of HIV-1 spikes for vaccine design using chemical tethers$473,750
R56 · FY2011 · AI · contact PI
Targeting neutralizing antibody-defined sites on HIV gp41 for vaccine design$455,501
R01 · FY2011 · AI · contact PI
Investigating an interface between gp120 and gp41 for HIV entry inhibition$331,625
R21 · FY2011 · AI · contact PI
Targeting neutralizing antibody-defined sites on HIV gp41 for vaccine design$460,102
R01 · FY2010 · AI · contact PI
Targeting neutralizing antibody-defined sites on HIV gp41 for vaccine design$464,749
R01 · FY2009 · AI · contact PI
Engineering and sorting HIV-1 display Env libraries for vaccine design$262,452
R21 · FY2009 · AI · contact PI
Targeting neutralizing antibody-defined sites on HIV gp41 for vaccine design$464,749
R01 · FY2008 · AI · contact PI
Engineering and sorting HIV-1 display Env libraries for vaccine design$254,889
R21 · FY2008 · AI · contact PI
Targeting neutralizing antibody-defined sites on HIV gp41 for vaccine design$466,000
R01 · FY2007 · AI · contact PI
ANTIBODIES AGAINST HIV-1 gp41: TOOLS FOR VACCINE DESIGN$281,550
R21 · FY2005 · AI
ANTIBODIES AGAINST HIV-1 gp41: TOOLS FOR VACCINE DESIGN$281,550
R21 · FY2004 · AI